The Company anticipates 2026 revenues in the range of $60 million to $62 million.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSI:
- TriSalus Life Sciences reports Q4 EPS (21c), consensus (14c)
- TLSI Earnings this Week: How Will it Perform?
- TriSalus Life Sciences Prices Underwritten Public Equity Offering
- TriSalus Life Sciences 9.76M share Spot Secondary priced at $4.10
- TriSalus Life Sciences announces common stock offering, no amount given